Skip to main content

Find Clinical Trials

Home
Conditions
Medulloblastoma

Clinical trial condition

Medulloblastoma

Explore clinical trials studying Medulloblastoma. Study availability and eligibility vary by location and protocol.

250 public trials 38 recruiting studies

Refine in advanced search Browse all conditions

Medulloblastoma trial results

Recruiting

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

NCT06942039

Conditions: Atypical Teratoid Rhabdoid Tumor, Brain Diseases, Brain Neoplasms, +38 more
Locations: Alberta Children's Hospital Calgary, Alberta, Canada

BC Children's Hospital Vancouver, British Columbia, Canada

CancerCare Manitoba (CCMB) Winnipeg, Manitoba, Canada

IWK Health Centre Halifax, Nova Scotia, Canada

View Trial Details

Recruiting

A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)

NCT07698899

Conditions: CNS Metastases, Central Nervous System Metastasis, Glioma, +11 more
Locations: Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering at Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States

View Trial Details

Recruiting

CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation

NCT07085325

Conditions: Glioma, Medulloblastoma, Neoplasms, +7 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)

NCT07492316

Conditions: Glioma, Medulloblastoma, Neoplasms, +8 more
Locations: UF Health Shands Children's Hospital Gainesville, Florida, United States

View Trial Details

Recruiting

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

NCT06193759

Conditions: Atypical Teratoid/Rhabdoid Tumor of CNS, Brain Diseases, Brain Neoplasms, +23 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

View Trial Details

Recruiting

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

NCT06607692

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +57 more
Locations: HM Monteprincipe Boadilla del Monte, Madrid, Spain

View Trial Details

Recruiting

Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors

NCT07584499

Conditions: Atypical Teratoid/Rhabdoid Tumors, Carcinoma, Carcinoma, Squamous Cell, +53 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

NCT04185038

Conditions: Atypical Teratoid/Rhabdoid Tumor, Brain Diseases, Brain Neoplasms, +29 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Recruiting

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

NCT05106296

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +18 more
Locations: Augusta University, Georgia Cancer Center Augusta, Georgia, United States

View Trial Details

Recruiting

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

NCT04541082

Conditions: Anaplastic Astrocytoma, Anaplastic Meningioma, Anaplastic Oligodendroglioma, +41 more
Locations: National Institutes of Health Bethesda, Maryland, United States

View Trial Details